MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
about
Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancerTargeting microRNAs as key modulators of tumor immune responseMicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaMicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentPhenotype, development, and biological function of myeloid-derived suppressor cellsMyeloid-derived cells are key targets of tumor immunotherapyOverexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity.The roles of TGFβ in the tumour microenvironment.microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets.MicroRNA-20b promotes the accumulation of CD11b+Ly6G+Ly6Clow myeloid-derived suppressor cells in asthmatic miceStroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung CancerIntratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic CellsMicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN.MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsisAn intracameral injection of antigen induces in situ chemokines and cytokines required for the generation of circulating immunoregulatory monocytes.MicroRNA-494, upregulated by tumor necrosis factor-α, desensitizes insulin effect in C2C12 muscle cellsMicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancerLow serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.Gr-1⁺CD11b⁺ immature myeloid cells (IMC) promote resistance of pro-inflammatory T cells to suppression by regulatory T cells in atherosclerotic Apo E- deficient mice.A new method for discovering disease-specific MiRNA-target regulatory networksRegulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs.MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma CellsThe roles of microRNAs in the regulation of tumor metastasis.Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.Discriminating between Terminal- and Non-Terminal Respiratory Unit-Type Lung Adenocarcinoma Based on MicroRNA Profiles.MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.NFI-A disrupts myeloid cell differentiation and maturation in septic mice.A core of kinase-regulated interactomes defines the neoplastic MDSC lineage.Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.Myeloid-derived suppressor cells in breast cancer.In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
P2860
Q26741623-823D224F-0F34-403B-81DA-28426FCE6F95Q26746972-2B30FBC4-012F-4F5F-8176-A500327107ACQ26747339-93DEDB2D-B4B9-4C26-A4E1-E8B295C0886FQ26777313-11F13364-2917-4672-921C-E20ACC7A8819Q26799126-6A40E6CF-CEA7-4960-8493-061CF50D73B1Q28079046-B2DDB5FE-7A4E-4F59-BB02-8EE54FFDA607Q28388246-6A450398-24BD-43D7-994E-ED3E22F06E8AQ28396088-B3092969-5BAB-4221-A360-2FB361EC6EFCQ30411008-8C6DC714-9E40-4DE8-A232-5DF345397BDBQ30591772-C6EC8E4D-2E74-4710-9631-7263220F2BCFQ33598739-F5106487-2191-4C4B-970F-7DA47DD3117CQ33630845-62C3FBD8-87C6-432F-92D1-BEB63A5AA2FDQ33728647-CFFDB602-0D62-4DC1-86D8-2B8F3BFF07F3Q33797141-88709FA1-A1A1-451A-A17D-8A23C35D246EQ33837289-7DA79128-5DBA-4A8C-8D21-F1517320FC05Q33858506-1F40B59E-52E6-4508-8820-202474CB78BEQ34233531-2B8E3458-DBC2-41EA-944D-FF97260CF107Q34298403-556DC581-C2AB-40A8-A13A-74F365E905E4Q34389392-62B21754-3A87-4CA8-8E11-C9CE4FF441BAQ35070980-FBA48A24-B1B8-4112-B2DD-1BD3DC816CF1Q35128098-3CA3A3F8-EAF8-4C00-9862-6C11A8EEC338Q35246395-B0C5CBCA-B4AD-45AE-B3F7-39A69EF59D45Q35289139-90EF4404-44E3-415A-B7E9-56779DFE40E6Q35302572-F1002E8E-6B52-483C-AA10-6270E8CDD725Q35633856-A7EF5D9F-A806-4862-AB5E-8384505D86ACQ35748163-9C3B84FC-5F5D-46C6-8E77-C7ED6779AED8Q35748965-3DE9D095-B6C5-4BD8-BBD9-9FD9D528967BQ35770894-F504C688-4EAA-4C11-BADF-3D98AC66FAFAQ35816884-19302117-B8DC-4C0C-BBA9-C41BB7119FACQ35824254-86999902-5C7E-4915-87E6-A1EF080F9AD0Q36116742-B6EF003A-87C0-4FAC-BD6C-CC41E2114A17Q36339939-C68D83B1-89F3-4B6A-87F4-DF21D731CF47Q36356983-91444DEA-395F-42B6-8BB2-186433A2924CQ36413721-F527AC75-11E0-49C4-B2C3-BDEEB02F4087Q36597506-87B3E394-1FF9-4B81-BD59-7D366051A722Q36655845-673397F5-BFC1-49FB-9AD4-790A69789685Q36685269-C9B75D46-F753-4556-B3CB-49D6ABE0423CQ36962436-EB48641A-D2D0-4FCA-B496-5A329A5FC052Q37172813-27D60BB0-E0B3-4765-AE80-CA61EEA7398BQ37228217-49C1DFD7-C347-4A5D-BFC4-AE07475741D0
P2860
MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MicroRNA-494 is required for t ...... r cells via targeting of PTEN.
@en
MicroRNA-494 is required for t ...... r cells via targeting of PTEN.
@nl
type
label
MicroRNA-494 is required for t ...... r cells via targeting of PTEN.
@en
MicroRNA-494 is required for t ...... r cells via targeting of PTEN.
@nl
prefLabel
MicroRNA-494 is required for t ...... r cells via targeting of PTEN.
@en
MicroRNA-494 is required for t ...... r cells via targeting of PTEN.
@nl
P2093
P356
P1476
MicroRNA-494 is required for t ...... or cells via targeting of PTEN
@en
P2093
Jianli Wang
Qingqing Wang
Qingyun Chen
Xiaojian Wang
Xuetao Cao
Yinjing Song
P304
P356
10.4049/JIMMUNOL.1103505
P407
P50
P577
2012-04-27T00:00:00Z